LexDanaLexDanabeta
Inventor

Rajul JAIN

Inventor
US

Overview

4→
Patents
2022–2026
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
C12NMicroorganisms or enzymes13%
G01NInvestigating or analysing materials by determining their chemical or physical properties13%
PatentTitleYear
12,559,718Diagnostic methods for t cell therapy202612,458,654Methods of conditioning patients for T cell therapy202511,779,601Diagnostic methods for T cell therapy202311,491,187Methods of conditioning patients for T cell therapy2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2026Patents assigned to KITE PHARMA INC (4)· patent assignee history
2022–2025Patents assigned to US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES (3)· patent assignee history
2022–2023Patents assigned to US HEALTH (2)· patent assignee history
2022–2026Based in US· patent location history
2026Patents assigned to USA AS REPRESENTED BY THE SEC DEPT OF HHS (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
KITE PHARMA INC42022–2026
US SECRETARY DEPARTMENT OF HEALTH AND HUMAN SERVICES32022–2025
US HEALTH22022–2023
USA AS REPRESENTED BY THE SEC DEPT OF HHS12026
Locations
LocationPatentsSpan
US42022–2026